Soumettre un manuscrit
Entrez votre recherche:
Les critères de recherche
Résultats 1-2 (2)
Date de parution
Titre de revue
Aller au numéro de la page:
Notices sélectionnées (0)
Sélectionner un filtre
Annals of Clinical Microbiology and Antimicrobials (1)
Evidence-based Complementary and Alternative Medicine : eCAM (1)
Akah, Peter A. (1)
Esimone, Charles O (1)
Esimone, Charles O. (1)
Gatermann, Sören (1)
Iroha, Ifeanyichukwu R (1)
Kaase, Martin (1)
Korte, Miriam (1)
Marlinghaus, Lennart (1)
Neumann, Sandra (1)
Nworu, Chukwuemeka S. (1)
Szabados, Florian (1)
Année de publication
Type de document
First description of Escherichia coli producing CTX-M-15- extended spectrum beta lactamase (ESBL) in out-patients from south eastern Nigeria
Iroha, Ifeanyichukwu R
Annals of Clinical Microbiology and Antimicrobials
We studied the presence of extended spectrum beta lactamases (ESBLs) in 44 clinical isolates of Escherichia coli collected from out-patients in two university teaching hospitals in South-Eastern Nigeria. Species identification was performed by standard microbiology methods and re-confirmed by MALDI-TOF technology. Phenotypic characterization of ESBL enzymes was done by double disc synergy test and presence of ESBL genes was determined by specific PCR followed by sequencing. Transfer of plasmid DNA was carried out by transformation using E. coli DH5 as recipient strain. Phenotypic characterization identified all isolates to be ESBL positive. 77% of strains were from urine, 13.6% from vaginal swabs and 9.0% from wound swabs. 63.6% were from female patients, 68% were from outpatients and 95.5% from patients younger than 30 years. All ESBL producers were positive in a PCR for blaCTX-M-1 cluster, in exemplary strains blaCTX-M-15 was found by sequencing. In all strains ISEcp1 was found upstream and ORF477 downstream of blaCTX-M. PCR for blaTEM and blaOXA-1 was positive in 93.1% of strains, whereas blaSHV was not detected, aac(6′)-Ib-cr was found in 97.7% of strains. RAPD analysis revealed seven different clonal groups named A through G with the majority of the strains (65.9%) belonging to clone A. Transfer of an ESBL plasmid with co-resistance to gentamicin, kanamycin, tobramycin, doxycycline and trimethropim-sulfamethoxazole was successful in 19 (43.2%) strains. This study showed a high rate of CTX-M-1 cluster - ESBLs in South-Eastern Nigeria and further confirms the worldwide spread of CTX-M ESBL in clinical isolates.
Outpatients; ESBL; CTX-M; Escherichia coli
Efficacy and Safety Assessment of T. Angelica Herbal Tonic, a Phytomedicinal Product Popularly Used in Nigeria
Akah, Peter A.
Nworu, Chukwuemeka S.
Evidence-based Complementary and Alternative Medicine : eCAM
T. Angelica Herbal Tonic (TAHT) is a herbal product indicated for indigestion and constipation and highly patronized in Nigeria. In this study, the efficacy and safety of the herbal tonic in relation to the label claims were assessed. The effect on peristalsis in mice was evaluated by the charcoal meal model and in vitro using guinea pig ileum. The effects of TAHT on behavior, fertility, birth and organ weights were also determined. Teratogenic potential and reproductive toxicity were studied in pregnant rats. Acute toxicity studies showed that at doses above 5000 mg kg−1, the herbal tonic did not cause lethality and produced no signs of intoxication in mice. The study did not show any gross behavioral changes in mice treated with 1000 mg kg−1 of TAHT as compared with the negative control treatment. TAHT (400 mg kg−1) exhibited a dose-dependent enhancement in the gastrointestinal tract motility in mice when compared with the negative control. At concentrations up to 300 μg mL−1, TAHT did not cause any significant effect on acetylcholine, histamine and nicotine-evoked contractions of guinea pig ileum preparation. It took an average of 31.25 ± 4.52 days for the TAHT-treated animals to litter, which is significantly (P < .05) different from the 55 ± 4.51 days recorded for the control treatment group. TAHT exhibited a modest fertility-promoting effect and showed lack of abortifacient and teratogenic properties in the study. Generally, the results of this study showed some favorable pharmacological effects of TAHT in animals which may authenticate some of the label claims.
Résultats 1-2 (2)
Aller au numéro de la page:
Déselectionner cette notice
Sélectionnez cette notice
Toutes les notices sélectionnées seront supprimées. Continuer?
Maximum atteint! Retirer élément(s) et réessayer.
Avis de non-responsabilité
PubMed Central Canada est un service des
Instituts de recherche en santé du Canada
(IRSC) offert en partenariat avec l'
Institut canadien de l'information scientifique et technique
du Conseil national de recherches du Canada et le
National Center for Biotechnology Information
National Library of Medicine
(NCBI/NLM) des États-Unis. Il renferme entre autres du contenu des archives de
PubMed Central International